Trials for a new meningitis vaccine have produced “exciting” results that are encouraging signs for combating the disease in future.
Currently, there is no jab to safeguard against strains of meningitis B, which covers around 90% of cases in the UK.
It is a deadly form of the disease that can sometimes kill babies and toddlers in under four hours.
But new data on a 4CMenB vaccine has revealed that it can protect against an estimated 80% of 1,000 meningitis B strains from across Europe.
Results from 1,800 children discovered that it worked well both on its own and with vaccines for other strains of the disease.
Further research on 1,500 toddlers discovered that it offers protection when given as a booster jab, while another demonstrated immune response in teenagers.
Meningitis UK said the new vaccine could lead to thousands of lives being saved in the future.
Chief executive Steve Dayman said: “This data is a very positive step in the fight to eradicate meningitis B, which is the biggest killer of all types of meningitis in the UK.
“This vaccine is the first of its kind and has the potential to save thousands of lives.”
You can discuss this further on our Nursing Times forum, connect with your peers!